Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy/Effectiveness, Safety, and Immunogenicity of LC16m8 Mpox Vaccine in Colombia	DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease	Active, not recruiting	Phase 3	2025-09-04		NCT06223919

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Instituto Nacional de Salud	1
Japan Agency for Medical Research and Development	11
Ministerio de Salud y Protección Social de Colombia	1
Ministry of Health, Labour and Welfare, Japan	1
National Center for Global Health and Medicine, Japan	2
National Institute of Infectious Disease, Japan	1
Universidad Nacional de Colombia	7

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Clinica Universitaria Colombia - Centro Medico Teusaquillo	Bogotá	Colombia	1
Hospital Universitario San Ignacio	Bogotá	Colombia	3
Infecto Clinicos	Bogotá	Colombia	1